NVTA Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 vas. 2024 @ 22:59):

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally...

Stats
Šios dienos apimtis	22.46M
Vidutinė apimtis	12.70M
Rinkos kapitalizacija	5.44M
EPS	$0 ( 2024-02-27 )
Kita pelno data	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.00354
ATR14	$0.0380 (237.50%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-20	Nussbaum Robert L	Sell	17 404	Common Stock
2023-12-20	Brida Thomas	Sell	17 404	Common Stock
2023-11-13	Sholehvar David	Buy	850 000	Common Stock
2023-11-13	Sholehvar David	Buy	0
2023-10-18	Brida Thomas	Buy	229 500	Common Stock

INSIDER POWER
90.41
Last 92 transactions
Buy: 9 089 738 \| Sell: 529 241

Tūris Koreliacija

Ilgas: -0.23 (neutral)

Trumpas: -0.96 (very strong negative)

Signal:(21.881) Possible Trading Opportunity Present (swing)

Invitae Corp Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Invitae Corp Koreliacija - Valiuta/Žaliavos

-0.75
( moderate negative )

-0.78
( moderate negative )

0.85
( strong )

-0.79
( moderate negative )

0.75
( moderate )

Invitae Corp Finansinės ataskaitos

Annual	2022
Pajamos:	$516.30M
Bruto pelnas:	$99.05M (19.18 %)
EPS:	$-13.18

FY	2022
Pajamos:	$516.30M
Bruto pelnas:	$99.05M (19.18 %)
EPS:	$-13.18

FY	2021
Pajamos:	$460.45M
Bruto pelnas:	$111.78M (24.28 %)
EPS:	$-1.736

FY	2020
Pajamos:	$279.60M
Bruto pelnas:	$81.32M (29.09 %)
EPS:	$-4.52

Financial Reports:

No articles found.

Invitae Corp

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.